About DC Biosciences
DC Biosciences, formerly Dundee Cell Products, provides pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs.
Missing: DC Biosciences's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: DC Biosciences's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
DC Biosciences Frequently Asked Questions (FAQ)
When was DC Biosciences founded?
DC Biosciences was founded in 2006.
Where is DC Biosciences's headquarters?
DC Biosciences's headquarters is located at James Lindsay Place, Dundee.
What is DC Biosciences's latest funding round?
DC Biosciences's latest funding round is Other Investors.
Who are the investors of DC Biosciences?
Investors of DC Biosciences include Discovery Investment Fund.
Who are DC Biosciences's competitors?
Competitors of DC Biosciences include DiscoveryBioMed, Primorigen Biosciences, Guava Technologies, CytoBioscience, Blue Sky BioServices, BioSilta, Cellumen, DNA Software, CellAura Technologies, Cellomics and 14 more.
Compare DC Biosciences to Competitors
AVIVA develops enabling drug discovery technoSlogies by combining biochips with cell biology.
CellAura Technologies is a spin out company from the University of Nottingham, combining world-renowned expertise in the fields of synthetic chemistry and molecular pharmacology to produce high quality fluoresent G-protein coupled receptor ligands for use in molecular pharmacology and imaging at the single cell level.
Plectix BioSystems Inc. is focussed on approaches for overcoming challenges faced by biologists in the complex world of cell signaling.
IntelCell markets a product platform engineered to modernize research techniques for cell and tissue growth. The company's first product, Cell Drive, replaces traditional cell culture equipment by providing an unprecedented level of usability and sophistication for the user. For scientists whose research depends upon live cell culture, Cell Drive aims to offer a compact, precision, cell growth system that increases experimental control, aims to improve sterility, aims to provide digitization of data and methods, and aims to reduce human error and labor costs.
CellCura, Inc. is a company dedicated to the development of equipment and products for use in assisted reproductive technology (ART) and stem cell research.
BioSilta, founded in 2007 in Oulu, Finland, utilizes its unique, proprietary EnBase technology platform to develop innovative, reagent-based EnPresso growth systems. When compared to conventional growth media, these growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.